Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage.
Antelo-Pais P, Prieto-Díaz MÁ, Micó-Pérez RM, Pallarés-Carratalá V, Velilla-Zancada S, Polo-García J, Barquilla-García A, Ginel-Mendoza L, Segura-Fragoso A, Vitelli-Storelli F, Martín-Sánchez V, Hermida-Ameijerias Á, Cinza-Sanjurjo S; Investigators of the IBERICAN Study and of the Spanish Society of Primary Care Physicians (SEMERGEN) Foundation. Antelo-Pais P, et al. Among authors: barquilla garcia a. J Clin Med. 2022 Dec 21;12(1):50. doi: 10.3390/jcm12010050. J Clin Med. 2022. PMID: 36614852 Free PMC article.
[Blood pressure control in a population of hypertensive diabetic patients treated in primary care: PRESCAP-Diabetes Study 2010].
Barquilla García A, Llisterri Caro JL, Prieto Díaz MA, Alonso Moreno FJ, García Matarín L, Galgo Nafría A, Mediavilla Bravo JJ; representación del Grupo de Trabajo de Hipertensión Arterial de la Sociedad Española de Médicos de Atención Primaria (Grupo HTA/SEMERGEN) y de los investigadores del Estudio PRESCAP 2010. Barquilla García A, et al. Semergen. 2015 Jan-Feb;41(1):13-23. doi: 10.1016/j.semerg.2014.02.003. Epub 2014 Apr 3. Semergen. 2015. PMID: 24703582 Spanish.
[Control of anticoagulation in patients with non-valvular atrial fibrillation in a primary care clinical practice setting in the different autonomous communities. PAULA study].
Polo García J, Barrios Alonso V, Escobar Cervantes C, Prieto Valiente L, Lobos Bejarano JM, Vargas Ortega D, Prieto Díaz MÁ, Alonso Moreno FJ, Barquilla García A. Polo García J, et al. Semergen. 2017 Apr;43(3):207-215. doi: 10.1016/j.semerg.2016.05.004. Epub 2016 Jul 13. Semergen. 2017. PMID: 27422774 Spanish.
[Baseline characteristics and clinical management of the first 3,000 patients enrolled in the IBERICAN study (Identification of the Spanish population at cardiovascular and renal risk)].
Cinza Sanjurjo S, Prieto Díaz MÁ, Llisterri Caro JL, Pallarés Carratalá V, Barquilla García A, Rodríguez Padial L, Díaz Rodríguez Á, Polo García J, Vergara Martín J, Vidal Pérez R, Rodríguez Roca GC; en representación de los investigadores del estudio IBERICAN. Cinza Sanjurjo S, et al. Semergen. 2017 Oct;43(7):493-500. doi: 10.1016/j.semerg.2016.07.006. Epub 2016 Aug 23. Semergen. 2017. PMID: 27567214 Spanish.
[Positioning for the management of arterial hypertension in Primary Care from the critical analysis of the American (2017) and European (2018) guidelines. Spanish Society of Primary Care Physicians (SEMERGEN)].
Pallarés-Carratalá V, Divisón Garrote JA, Prieto Díaz MA, García Matarín L, Seoane Vicente MC, Molina Escribano F, Velilla Zancada S, Rey Aldana D, Cinza Sanjurjo S, Santos Altozano C, Górriz JL, Alonso Moreno FJ, Polo García J, Barquilla García A, Beato Fernández P, Escobar Cervantes C; en nombre del Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN; Miembros del Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN. Pallarés-Carratalá V, et al. Semergen. 2019 May-Jun;45(4):251-272. doi: 10.1016/j.semerg.2019.02.003. Epub 2019 Apr 18. Semergen. 2019. PMID: 31005506 Spanish.
[Description of the sample, design and methods of the study for the identification of the Spanish population at cardiovascular and renal risk (IBERICAN)].
Cinza Sanjurjo S, Llisterri Caro JL, Barquilla García A, Polo García J, Velilla Zancada S, Rodríguez Roca GC, Micó Pérez RM, Martín Sánchez V, Prieto Díaz MÁ; en representación de los investigadores del estudio IBERICAN. Cinza Sanjurjo S, et al. Semergen. 2020 Jan-Feb;46(1):4-15. doi: 10.1016/j.semerg.2019.10.006. Epub 2019 Dec 20. Semergen. 2020. PMID: 31870705 Spanish.
[Factors associated with cardiovascular risk and cardiovascular and renal disease in the IBERICAN study: Final results].
Cinza-Sanjurjo S, Micó-Pérez RM, Velilla-Zancada S, Prieto-Díaz MA, Rodríguez-Roca GC, Barquilla García A, Polo García J, Martín Sánchez V, Llisterri Caro JL; en representación de los investigadores del estudio IBERICAN. Cinza-Sanjurjo S, et al. Semergen. 2020 Sep;46(6):368-378. doi: 10.1016/j.semerg.2020.06.027. Epub 2020 Aug 30. Semergen. 2020. PMID: 32873502 Spanish.
33 results